SciVision Biotech Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 132.21 million compared to TWD 126.8 million a year ago. Net income was TWD 39.66 million compared to TWD 31.63 million a year ago. Basic earnings per share from continuing operations was TWD 0.6 compared to TWD 0.48 a year ago. Diluted earnings per share from continuing operations was TWD 0.6 compared to TWD 0.47 a year ago.
For the six months, sales was TWD 232.58 million compared to TWD 238.03 million a year ago. Net income was TWD 66.63 million compared to TWD 56.27 million a year ago. Basic earnings per share from continuing operations was TWD 1.01 compared to TWD 0.85 a year ago. Diluted earnings per share from continuing operations was TWD 1 compared to TWD 0.84 a year ago.